QUCY Quantum Cyber N.V.

NEUTRAL Impact: 3/10 144
Horizon days Filed May 22, 2026 Processed 18d 13h ago SEC 0001959173-26-003912
Form 144 — notice of proposed sale of securities
Latest settled — T+5d
QUCY ▼ -33.03% at T+5d
NEUTRAL call ✗ call lost -33.03% · α vs SPY -34.71% · entry $3.33 → $2.23
Next anchor: T+20d in 13d
Last close $2.10 (close Jun 8) · -36.94% from $3.33 entry
Entry anchored
May 22, 12:28 PM ET
via Databento tick
T+1d
+4.20%
call +4.20% · α +3.62%
$3.47
settled 15d ago
T+5d
-33.03%
call -33.03% · α -34.71%
$2.23
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Director Guido Baechler filed a Form 144 to sell 240,000 shares of Quantum Cyber (QUCY), valued at approximately $904,800, representing roughly 1.6% of shares outstanding. The sale comes from a stock award granted April 22, 2026, and the insider's remaining beneficial ownership of ~14.6M shares suggests this is a modest portfolio diversification move, not a material shift in insider conviction.

Actionable Insight

The 144 filing signals Baechler's intention to sell shares ahead of potential price weakness, but the 240K share sale is only ~1.6% of a small float, and he retains ~14.7M shares, so the economic impact on liquidity is manageable. Monitor for actual execution (Form 4 filings) and any follow-on insider sales from other officers, particularly ahead of the company's next quarterly report.

Key Facts

  • Guido Baechler, a Director and Officer, intends to sell 240,000 shares via Form 144 filed May 22, 2026
  • Estimated aggregate sale value: $904,800 based on a market price suggestion in the filing
  • Shares to be sold were acquired via stock award on April 22, 2026, as compensation from the issuer
  • Baechler's remaining beneficial ownership post-sale would be approximately 14,661,169 shares
  • The filing indicates a prior sale of 200,000 shares was executed on or around May 18, 2026, with proceeds of $730,699.41
  • QUCY is a micro-cap pharmaceutical preparation company with a $52M market cap and predominantly bearish analyst consensus (0% bullish)

Financial Impact

Notable insider sale of ~$904K in stock, roughly 1.6% of market cap; precedes a prior sale of ~$731K earlier in May

insider holdingsfloatdilution

Risk Factors

  • Insider selling ahead of a potentially disappointing catalyst or earnings release could pressure QUCY shares
  • Micro-cap pharma stocks are inherently volatile; even modest selling can amplify downward moves in thin trading
  • The prior May 18 sale of 200K shares suggests a pattern of systematic portfolio reduction that may continue

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003912
Document: 0001959173-26-003912-index.html0001959173-26-003912
Document: 0001959173-26-003912.txt0001959173-26-003912
19 reports for QUCY
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+5▲ +16.85%Apr 28, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
Type Now
Jun 5, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$2.19 awaiting T+1awaiting T+1$2.10 (−3.89%)
Jun 4, 2026
5d ago
S-3
BEARISH ★ 7/10
$2.33 $2.20▲ +5.58%▲ +2.98%$2.10 (+9.87%)
Jun 3, 2026
6d ago
8-K
MIXED ★ 5/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.10 (−14.63%)
Jun 3, 2026
6d ago
Press Release
NEUTRAL ★ 3/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.10 (−14.63%)
Jun 2, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$2.45 $2.46▲ +0.41%▲ +1.10%$2.10 (−14.29%)
May 27, 2026
13d ago
Press Release
NEUTRAL ★ 4/10
$2.93 $2.98▲ +1.71%▲ +1.15%$2.10 (−28.33%)
May 26, 2026
14d ago
Press Release
BULLISH ★ 7/10
$3.47 $2.93▼ −15.56%▼ −15.58%$2.10 (−39.48%)
May 22, 2026
18d ago
144
NEUTRAL ★ 3/10
$3.33 $3.47▲ +4.20%▲ +3.62%$2.10 (−36.94%)
May 20, 2026
20d ago
Press Release
NEUTRAL ★ 4/10
$3.29 $3.56▲ +8.21%▲ +8.01%$2.10 (−36.17%)
May 18, 2026
22d ago
144
BEARISH ★ 5/10
$2.52 $3.29▼ −30.56%▼ −29.52%$2.10 (+16.67%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 7h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access